Lung Therapeutics, Inc. — Form D/A
Lung Therapeutics, Inc. of Austin, TX, a company, filed a Form D amendment with the SEC on 2019-10-31. The offering totals $38.7M, of which $38.7M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2019-10-31
- Form: D/A
- Accession: 0001209191-19-054587
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $38.7M
- Amount sold: $38.7M
- Investors: 42
- Date of first sale: 2019-05-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-258787
Issuer
- Name: Lung Therapeutics, Inc.
- CIK: 0001611241
- Entity type: Corporation
- Jurisdiction: TEXAS
- Incorporated: 2012
- Address: 3801 S. Capital of TX Hwy, Austin, TX, 78704
- Phone: 737-802-1989
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Aaron Brian Fletcher | Director | Fort Worth, TX |
| Steven Brian Idell | Director | Tyler, TX |
| Robert Brian Mills | Director | Naples, FL |
| R. A Session | Director | Dallas, TX |
| James Brian Windsor | Director | Austin, TX |
| James Brian Windsor | Executive Officer | Austin, TX |
| Aaron GL Fletcher | Director | FORT WORTH, TX |
| Charles C Garner | Executive Officer | Austin, TX |
| William C Fairey | Director | Austin, TX |
| Brian Windsor | Director | Austin, TX |
| Brian Windsor | Executive Officer | Austin, TX |
| Jim Brian Mervis | Director | Los Angeles, CA |
| Joseph Brian Woelkers | Director | Tyler, TX |
Other filings by this issuer (9)
More